iSpecimen: Premier Online Marketplace for Human Biospecimens

Aug. 11, 2021
iSpecimen (Nasdaq: ISPC) is a technology-driven company bringing innovation and digitization to human biospecimen procurement, estimated to be a $3-$4 billion annual global market. The Company’s iSpecimen Marketplace platform connects life science researchers who need human biofluids, tissues, and living cells (“biospecimens”) for their research with the billions of biospecimens available, but not easily accessible, at healthcare provider organizations worldwide. The ground-breaking technology is transforming the highly fragmented and inefficient biospecimen procurement process by consolidating the buying experience in a single, online marketplace – connecting healthcare providers who have biospecimens with the growing number of researchers who need them. Tapping into the power of healthcare data, iSpecimen’s unique platform allows researchers to easily search for and select research subjects, biospecimens, and their associated data sets to drive their research programs, while keeping the identities and sensitive information of patients private. It then orchestrates and manages the biospecimen procurement workflows of both researchers and suppliers to bring efficiencies and compliance to the entire buying process. Through the iSpecimen Marketplace, researchers gain instant access to millions of specimens anytime, anywhere, while participating supply organizations gain an opportunity to contribute compliantly to medical research while increasing their revenue and sustainability. Ultimately, healthcare improves for all. Visit to learn more.

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market